UK Markets closed

CynergisTek, Inc. (CTEK)

NYSE American - Nasdaq Real-time price. Currency in USD
Add to watchlist
1.2400+0.0100 (+0.81%)
At close: 03:59PM EDT
1.2400 0.00 (0.00%)
After hours: 06:57PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 1.30
52-week change 3N/A
S&P500 52-week change 3N/A
52-week high 32.4400
52-week low 30.5800
50-day moving average 31.2016
200-day moving average 31.2745

Share statistics

Avg vol (3-month) 3278.32k
Avg vol (10-day) 341.45k
Shares outstanding 513.19M
Implied shares outstanding 6N/A
Float 810.88M
% held by insiders 19.21%
% held by institutions 123.04%
Shares short (14 Jul 2022) 458.1k
Short ratio (14 Jul 2022) 40.41
Short % of float (14 Jul 2022) 40.48%
Short % of shares outstanding (14 Jul 2022) 40.44%
Shares short (prior month 14 Jun 2022) 4202.3k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 312 Jan 2017
Ex-dividend date 4N/A
Last split factor 21:3
Last split date 312 Jan 2017

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)30 Mar 2022


Profit margin -13.12%
Operating margin (ttm)-49.88%

Management effectiveness

Return on assets (ttm)-18.50%
Return on equity (ttm)-9.57%

Income statement

Revenue (ttm)16.79M
Revenue per share (ttm)1.33
Quarterly revenue growth (yoy)11.70%
Gross profit (ttm)5.99M
Net income avi to common (ttm)-2.2M
Diluted EPS (ttm)-1.0770
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)1.21M
Total cash per share (mrq)0.09
Total debt (mrq)16.25k
Total debt/equity (mrq)0.07
Current ratio (mrq)2.26
Book value per share (mrq)2.04

Cash flow statement

Operating cash flow (ttm)-3.87M
Levered free cash flow (ttm)-1.61M